{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:10:20Z","timestamp":1733530220489,"version":"3.30.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jdmv.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:34:54Z","timestamp":1731706494000},"page":"222-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management challenges of recurrent venous thromboembolism in advanced digestive cancers: Case studies and therapeutic strategies"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-3279","authenticated-orcid":false,"given":"C.","family":"Doutrelon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Matray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Delamarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Razafinimanana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Charry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Cournac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jacquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Billhot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2024.10.002_bib0115","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/ATVBAHA.123.318779","article-title":"Updates in the incidence, pathogenesis, and management of cancer and venous thromboembolism","volume":"43","author":"Girardi","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0120","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15491","article-title":"Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"19","author":"Khan","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0125","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0135","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.acvd.2023.11.006","article-title":"Recurrent venous thromboembolism in anticoagulated cancer patients: diagnosis and treatment","volume":"117","author":"Bertoletti","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.111.051920","article-title":"Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism","volume":"126","author":"Louzada","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0150","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/jth.14783","article-title":"Prognosis in patients with cancer-associated venous thromboembolism: comparison of the RIETE-VTE and modified Ottawa score","volume":"18","author":"Pfaundler","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0155","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"7","author":"Carrier","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.rmr.2021.03.001","article-title":"Traitement de la maladie veineuse thromboembolique au cours du cancer. Mise \u00e0 jour mars 2021","volume":"38","author":"Mah\u00e9","year":"2021","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0165","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0170","first-page":"101056","article-title":"French guidelines for the treatment of cancer-associated venous thromboembolism\u00a0\u2013\u00a02023 update","volume":"84","author":"Mah\u00e9","year":"2023","journal-title":"Respir Med Res"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0175","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.3390\/curroncol28060453","article-title":"Treatment algorithm in cancer-associated thrombosis: updated canadian expert consensus","volume":"28","author":"Carrier","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.thromres.2014.04.028","article-title":"Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis","volume":"134","author":"Ihaddadene","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3747\/co.22.2392","article-title":"Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations","volume":"22","author":"Carrier","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0190","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0195","first-page":"259","article-title":"Cancers digestifs et thromboses\u00a0: quelles nouvelles recommandations\u00a0?","volume":"27","author":"Ballerie","year":"2020","journal-title":"Hepatogastro Oncol Dig"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0200","doi-asserted-by":"crossref","first-page":"e062768","DOI":"10.1136\/bmjopen-2022-062768","article-title":"Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study","volume":"13","author":"T\u00f8nnesen","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaccao.2023.09.003","article-title":"Cancer-associated thrombosis: trends in clinical features, treatment, and outcomes from 2001 to 2020","volume":"5","author":"Bertoletti","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1055\/s-0041-1735194","article-title":"Apixaban and dalteparin for the treatment of venous thromboembolism in patients with different sites of cancer","volume":"122","author":"Agnelli","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/jth.12955","article-title":"Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis","volume":"13","author":"Schulman","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2024.10.002_bib0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/VHRM.S331614","article-title":"Inhibition for the prevention of venous thromboembolism: an update on current evidence and future perspectives","volume":"18","author":"Poenou","year":"2022","journal-title":"Vasc Health Risk Manag"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451324001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451324001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T23:45:04Z","timestamp":1733528704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542451324001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2542451324001585"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2024.10.002","relation":{},"ISSN":["2542-4513"],"issn-type":[{"type":"print","value":"2542-4513"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management challenges of recurrent venous thromboembolism in advanced digestive cancers: Case studies and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}